Jan 08, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.36 to $0.02.
The split itself did not change the total investment value.
Oncternal Therapeutics, Inc. (ONCT) trades on the NASDAQ Capital Market in the Biotechnology industry.
Oncternal Therapeutics, Inc. company overviewThe latest split shown was on January 8, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 3 reverse splits between December 6, 2016 and January 8, 2024.